WHO Launches Global Offensive Against Mpox, Seeking $135 Million to Combat Resurgence
The World Health Organization (WHO) has announced a new global campaign to combat the persistent threat of Mpox (formerly known as monkeypox). The initiative, requiring $135 million in funding, will run from September 2024 to February 2025, aiming to bolster surveillance and response strategies, ensure equitable access to diagnostics and vaccines, and curb animal-to-human transmission.
This proactive approach comes at a crucial time. While the global Mpox outbreak declared in 2022 has shown signs of slowing, recent data reveals a concerning trend. The WHO reports a 20% increase in cases in the last week of July 2023 compared to the previous week, highlighting the virus’s potential for resurgence.
The campaign’s core objective is to break the chains of Mpox transmission. This will involve prioritizing vaccinations for individuals at highest risk, including healthcare workers and those in close contact with infected individuals. By creating a protective barrier around the most vulnerable, the WHO aims to limit the virus’s ability to spread.
Beyond immediate response, the campaign emphasizes strategic leadership and guidance. This includes ensuring that vulnerable populations in affected areas have access to essential medical treatment. The WHO recognizes that equitable access to healthcare is paramount in effectively controlling the outbreak and mitigating its impact on marginalized communities.
The WHO’s call for urgent funding underscores the need for a unified global effort. Combating Mpox effectively requires coordinated action at international, regional, and national levels. By investing in robust surveillance, equitable access to healthcare, and strategic interventions, the global community can work together to contain the virus and protect public health.
